PLA2R1 and cancer: It is widely acknowledged that PLA2R is the most important antigen in primary membranous nephropathy, but a study has revealed that 16 (5.3%) of the 302 patients with PLA2R antibody-positive MN were found to have malignant tumors within 24 months after the diagnosis of MN (10).